This summary was created by AI, based on 3 opinions in the last 12 months.
Experts are speculating on the impact of new weight-loss drugs on General Mills' snack-food sales, but so far, there has been no slowdown in the packaged food industry. Although the high-end pet food business has experienced a slowdown, the company is shifting towards more value-oriented pet products. However, there is concern that the wider economic weakening may have an adverse effect on the company's outlook.
It reports Wednesday. He suspects shares have been out of fears of the new weight-loss drugs eating into their snack-food sales. That said, every package food company that has reported has reported no slowdown, and those stocks rallied. GIS also had a good pet food business.
They report Wednesday; can they turn things around after sales faltered last quarter? Their high-end pet food business has stalled and Zoetis revealed that pet spending is slowing.
Their outlook is dimming as the wider economy weakens, and they're shifting to more value-oriented products for pets. He thought pet food was a more reliable product category but now this is can be slippery.
General Mills is a American stock, trading under the symbol GIS-N on the New York Stock Exchange (GIS). It is usually referred to as NYSE:GIS or GIS-N
In the last year, 2 stock analysts published opinions about GIS-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for General Mills.
General Mills was recommended as a Top Pick by on . Read the latest stock experts ratings for General Mills.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered General Mills In the last year. It is a trending stock that is worth watching.
On 2024-10-11, General Mills (GIS-N) stock closed at a price of $70.81.
They report Wednesday. They just sold their North American yogurt business for $2.1 billion, while their snacks and pet food visions are strong. The stock is a bargain now.